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Abstract
Functional nanomaterials have recently attracted strong
interest from the biology community, not only as potential
drug delivery vehicles or diagnostic tools, but also as optical
nanomaterials. This is illustrated by the explosion of
publications in the field with more than 2,000 publications
in the last 2 years (4,000 papers since 2000; from ISI Web of
Knowledge, ‘nanoparticle and cell’ hit). Such a publication
boom in this novel interdisciplinary field has resulted in
papers of unequal standard, partly because it is challenging
to assemble the required expertise in chemistry, physics, and
biology in a single team. As an extreme example, several
papers published in physical chemistry journals claim
intracellular delivery of nanoparticles, but show pictures of
cells that are, to the expert biologist, evidently dead (and
therefore permeable). To attain proper cellular applications
using nanomaterials, it is critical not only to achieve efficient
delivery in healthy cells, but also to control the intracellular
availability and the fate of the nanomaterial. This is still an
open challenge that will only be met by innovative delivery
methods combined with rigorous and quantitative character-
ization of the uptake and the fate of the nanoparticles. This
review mainly focuses on gold nanoparticles and discusses
the various approaches to nanoparticle delivery, including
surface chemical modifications and several methods used to
facilitate cellular uptake and endosomal escape. We will also
review the main detection methods and how their optimum
use can inform about intracellular localization, efficiency of
delivery, and integrity of the surface capping.
Keywords: gold nanoparticles; cell delivery; bionanotechnology;
nanomaterials; photothermal microscopy; cell imaging; intracellular
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G
old nanoparticles have emerged as attractive
nanomaterials for biological and biomedical
applications because of their physical and che-
mical properties (113) (Fig. 1). The gold core is inert
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1and essentially non-toxic to cells (14). The particles
absorb and resonantly scatter visible and near-infrared
light upon excitation of their surface plasmon oscillation.
The plasmon resonance band can be tuned over a wide
spectral range by changing intrinsic parameters such as
the material (bi-metallic or hybrid particles), the size, or
the shape (sphere, rod, cube, triangle, cage, etc.) (15). The
light-scattering signal is intense and much brighter than
chemical fluorophores and does not photobleach or blink
(16). This constitutes an advantage for their applications
in single molecule imaging, where the use of dyes,
fluorophores, or quantum dots is limited by low signal
intensities, complex blinking phenomena, and photo-
bleaching. For particles below 30 nm, the absorption
becomes dominant over scattering and can be used for
detection by photothermal microscopy (17). Gold nano-
particles with varying core size are prepared by the
reduction of gold salts in the presence of stabilizing
agents to prevent nanoparticle agglomeration and con-
trol growth (1822). Particle suspensions are also com-
mercially available. Furthermore, gold nanoparticles can
be easily functionalized by anchoring thiol linkers in
their monolayers. A wide variety of functional bionano-
conjugates has been obtained, including nanoparticles
modified with peptides, proteins, antibodies, oligosac-
charides, and nucleic acids (2329) (for review, see
References 6, 12). This allows the nanomaterials to act
as multifunctional platforms for both therapeutic and
diagnostic purposes (5, 30, 31).
The use of functionalized gold nanoparticles for biolo-
gical and biomedical applications includes bio-imaging,
single molecule tracking, biosensing, drug delivery, trans-
fection, and diagnostic. For example, through proper
functionalization, the particles can be engineered to
accumulate preferentially in tumor cells using targeting
ligands, providing a tool for cancer diagnosis and gene
therapy (32). Sensor arrays have been developed to
differentiate normal, cancerous, and metastatic cells using
the fluorescence quenching properties of gold nanoparti-
cles (30). The interactions and fate of a broad range of
functionalized nanoparticles is currently under investiga-
tion in awide diversity of biological models, ranging from
whole organisms to tissues to cells in culture, and also to
yeast (33) and prokaryote bacteria (34). The needs of
intracellular delivery depend on the applications. For
cancer cell targeting and killing, the requirement is proper
cell recognition and uptake independently of the ultimate
localization (e.g. vesicular localization is not a problem in
this context). However, for intracellular imaging and
sensing, cell recognition is less important, whereas the
ultimate intracellular localization of the nanomaterial is
crucial and needs to be fully addressed.
Here, we will focus on the delivery and detection of
nanoparticles (with a particular emphasis on gold) into
mammalian cells. Many biomedical applications will
ultimately necessitate a targeted intracellular delivery
and availability of the nanomaterial, not only to specific
cells, but also to specific subcellular compartments.
Currently, the main challenge is to avoid endosomal
localization and to control the stability of the functional
capping after cellular uptake. This review discusses how
the physico-chemical properties of the particles affect
cellular uptake and the current approaches under study
for intracellular delivery and control of subcellular
localization. We will review the different techniques
used for gold nanoparticles imaging and quantification
Fig. 1. Properties and potential applications of gold nanoparticles in biology and medicine.
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probe the integrity of the functional capping inside the
cellular compartment.
Non-specific cellular uptake
The plasma membrane defines the separation between
the interior of a cell and the outside environment. It is
semi-permeable and allows free diffusion of small and
non-polar molecules. However, bigger objects such as
nanomaterials are incapable of crossing the plasma
membrane and require uptake mechanisms such as
endocytosis (for review, see References (35) and (36)).
Most gold nanoparticle bioconjugates are easily taken up
by the cells through endocytotic mechanisms, but they
remain trapped in endosomal vesicles and are incapable
of reaching the cytosol. Although endocytotic uptake is
the norm for a broad range of nanomaterials, its
efficiency is dependent on the nanoparticle surface
chemistry and the physical properties (size and shape)
of the material.
Surface chemistry
Incubation of nanomaterials with live cells implicates
their exposure to cell culture medium often containing
serum. There are evidences suggesting that non-specific
interaction of serum proteins has a major effect on
uptake. Increase in uptake after 12 h incubation in fetal
calf serum (FCS) was observed for superparamagnetic
iron oxide nanoparticles (SPIONs) covered with a silane
layer (37). Significant difference of uptake was observed
for different surface chemistry, such as layer terminated
with COOH, NH2, and PEG, but this difference essen-
tially vanished when the particles had been exposed to
FCS for several hours (37). In another study, an excellent
correlation was found between adsorption of albumin
and uptake of a series of functionalized polystyrene
particles (Fig. 2) (38). In addition, after removing selected
components from the serum, the authors concluded that
the uptake does not depend on the identity of proteins
adsorbed to particle surfaces, but rather on the capacity
of the surfaces to bind protein and they propose that an
assessment of adsorptive capacity could be used to
predict nanoparticlecell interactions.
Using mixed monolayers containing oligonucleotides
on 13 nm gold nanoparticles, Giljohan et al. observed a
correlation between oligonucleotide loading and cell
uptake. They also observed an increase in size after
exposure to serum correlated with the amount of
oligonucleotide and concluded that serum proteins play
a key role in mediating nanoparticlecell interaction and
uptake of oligonucleotide-capped nanoparticles (39).
One way to prevent non-specific interactions of serum
proteins with nanoparticles is surface functionalization
with polyethylene glycol (PEG) (40). There is a consensus
on the role of PEG to strongly reduce nanomaterial
interaction with cells, thereby impairing their intracellular
uptake. PEGylation of nanorods was used to reduce non-
specific binding of herceptin-coated nanorods, leading to
specific recognition of the cancer cell lines presenting the
antigen (41). No significant uptake could be obtained for
10 nm gold nanoparticles decorated with PEG 5000,
however an increase of more than a factor 10 was
obtained by including a small proportion of a signaling
peptide in the layer through ligand exchange (42). Nativo
et al. found that uptake in HeLa cells of 16 nm
nanoparticles prepared by the Turkevich-Frens method
was completely stopped if these particles were protected
by a ligand shell terminatedwith tetraethylene glycol (43).
Evenafter prolonged incubation for 24 h or after a 10-fold
increase in concentration, no particles were found inside
the cells by transmission electron microscopy (TEM), and
no gold was detected by atomic emission spectroscopy
(AES) (43). Similarly, the uptake of large core-shell
polymer beads was reduced by PEGylation (44).
However, two studies seem to contradict the apparent
consensus on the effect of PEG. In the first study, Liu et
al. reported high uptake of 4.7 nm PEGylated gold
nanoparticles in CT26 cells and subsequent X-ray
irradiation cell damage (42). One possible explanation
resides in the fact that the PEG molecule used is not
Fig. 2. Uptake of functionalized polystyrene particles in
HUVEC cells correlate with protein adsorption capacity
(adapted from Reference 38). The lines indicate standard
deviation from three independent experiments. Reproduced
from Ehrenberg MS, Friedman AE, Finkelstein JN, Ober-
dorster G, McGrath JL. The inﬂuence of protein adsorption
on nanoparticle association with cultured endothelial cells.
Biomaterials 2009; 30: 60310. Copyright 2009 with permis-
sion from Elsevier.
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functionalized with PEG. In the second study, Gu et al.
observed avery slow (plateau after  30 h) but significant
uptake of 34 nm gold nanoparticles that had been
functionalized with PEG in a two-step functionalization
process (45). Even more surprisingly, the paper presents
convincing evidence of localization of the nanoparticles
in the nucleosomes. We suggest that the end-group of the
particular PEG used (amino-propyl) may play a role, but
a definite interpretation of this observation will require
further investigation.
Surface structure
In 2004, Jackson et al. reported the synthesis of stripy
nanoparticles based on scanning tunneling microscopy
observation (46). In subsequent papers, a number of
unusual properties were claimed for these new materials,
including, most recently, their ability to penetrate the
plasma membrane without disruption (47). Both the
structure and the properties of these particles are,
however, a matter of controversy (48).
Size and a few small complications
Size
The synthesis of gold nanoparticles can be controlled to
obtain particles in a large range of sizes. This has allowed
Chithrani et al. to evaluate nanoparticle entry into HeLa
cells for particles in the 14100 nm size range (49). The
authors found that maximum entry is observed for a 50-
nm diameter sphere (Fig. 3A). More recently, building on
progress in the size-controlled synthesis of silica, Lu et al.
have measured in the same cell line how entry of spherical
mesoporous silica beads vary in the 30280 nm size range
(50) (Fig. 3B). The latter paper concluded that their
results are in agreement with Chithrani et al., but careful
observation of the results indicates a more complicated
picture. While in the first paper, uptake is measured in
number of particles per cell, in the second, it is measured
in picogram of materials per cell. If expressed in pg/cell,
the results by Chithrani et al. indicate a plateau around
100 nm rather than a peak at 50 nm (Fig. 3C).
The debate on a maximum size for internalization is
still open. Some authors report a maximum size for
Fig. 3. Comparison of nanoparticle uptake as a function of size reported by (a) Chithrani et al. (49) and (b) Lu et al. (50). (c)
The results of Chithrani et al. are re-plotted with the particle uptake expressed in pg/cell (as in Reference 50) instead of number
of particles per cell. (A and C) Adapted with permission from Chithrani et al. (49). Copyright 2006 American Chemical Society.
(B) Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
Small 2009; 5: 140813. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
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beads are not taken by mouse melanoma B16 cells (51).
However, gold nanowires that have a 200-nm diameter
and a length of several micrometers have been observed
to be taken up by fibroblast and HeLa cells (52).
Kinetics of entry
One difficulty in comparing various studies is that most
papers present a still picture for a given time of
incubation. There have been very few comprehensive
quantitative studies of the kinetics of interaction and
uptake of nanomaterials in cells. According to some
reports, equilibrium (or saturation) takes several hours
and is size dependent. Rejman et al. reports significant
changes in the dynamics of uptake for latex beads
between 50 and 500 nm in murine melanoma cell line
B16-F10. The saturation time increased with size from
 30 min (50100 nm beads) to several hours (200 nm
beads) (51). Hartig et al. present a detailed kinetic
analysis of 140 nm positively charged fluorescent polymer
beads interactions with endothelial cells (53). They
observe extensive cooperativity and do not approach
saturation uptake in the range of concentration accessi-
ble. At the complete opposite, a report on carbon
nanotubes indicates an almost instantaneous equilibrium
with the cell having a similar endo- and exocytosis rate
that keeps the intracellular concentration constant (54).
Clustering
Another difficulty in comparing various published stu-
dies is to know exactly which species are taken up by the
cell. Is it single nanoparticles or aggregates formed prior
to, or during interaction with the membrane? Salmaso et
al. used particles capped with a thermoresponsive poly-
mer to control aggregation. The results showed an
increase in uptake upon aggregation (55). Surface pre-
sentation has been proposed as an original approach
aiming at better controlled delivery conditions (56).
Chithrani et al. have reported that single 50 nm
transferrin-coated gold nanoparticles are able to enter
cells, while 14 nm transferrin-coated nanoparticles were
only taken up when clustered in groups of at least six
particles (57). However, in our own experiments on the
entry of peptide-capped nanoparticles in HeLa cells, we
have observed endosomes containing single 10 nm
nanoparticles (Fig. 4). A possible explanation for these
apparently conflicting results may be the functionaliza-
tion of the nanoparticles (transferrin versus peptide/PEG)
and its effect on uptake mechanism. Real-time single
particle imaging will be necessary to better understand
this phenomenon and its impact on uptake.
Shape and rigidity
It has been suggested that uptake was higher for gold
nanoparticles than for gold nanorods (49). This was
based on the observation of enrichment of the number of
spheres in endosomes when HeLa cells were exposed to a
suspension of particles containing a mixture of rods and
a small proportion of spheres. Similar trends were
reported in a study of the influence of shape and rigidity
on uptake by macrophages using polystyrene particles
(58). Polystyrene particles of identical volumes but
different shapes were obtained by stretching the particles
embedded in a polymer film. The extended flexible
(‘worm-like’) particles exhibited negligible phagocytosis
when compared to spherical particles (58). However,
the same question was also addressed using a series of
size-controlled nanohydrogel particles and in these con-
ditions the high aspect ratio particles (d150 nm, h
450 nm) were internalized by HeLa cells approximately
four times faster than the more symmetric low aspect
ratio particles (d200 nm, h200 nm). In the latter
study, the particles were being dosed at constant particle
mass (15 mg/ml) (59).
It is remarkable that after several thousand publica-
tions on the interaction of particles with cells, simple
questions such as the effect of size or particle chemistry
on nanoparticle uptake in cells are not settled. The most
likely explanation is that while the question is simple, the
answer is not: the effect of size is not independent ofother
parameters such as surface chemistry, cell line, colloidal
stability, non-specific interactions, etc. It is therefore
possible that high-throughput approaches with systematic
variations of material parameters will be required to
reach a better understanding of nanomaterialscell inter-
actions. Passive uptake of nanomaterials always results in
endosomal localization. This is a stringent limitation for
biological and biomedical applications and therefore
considerable efforts are being made to escape or bypass
the endocytotic pathway. In the next section, we examine
Fig. 4. Transmission electron microscopy image of the
uptake of 10 nm gold nanoparticles coated with 10%
CALNN-HA2  20% CALNN-PEG  70% CALNN. The
particles (6 nM) were incubated in the presence of serum
with HeLa cells for 3 h before ﬁxation and TEM imaging.
The scale bar is 500 nm.
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entry into cells.
Facilitated delivery
A number of strategies for biomolecule delivery, espe-
cially anti-sense oligonucleotides and DNA have been
developed (for review, see Reference (60)). They include
the use of penetrating peptides, polycationic molecules,
liposomes, and methods involving physical transient
disruption of the plasma membrane. Most of these
methods have been applied to nanomaterials and
gold nanoparticles and their efficiency for intracellular
delivery and cytoplasmic availability of the cargo will be
discussed.
Cell-penetrating peptides
Over the past 15 years, carrier delivery methods have
been developed to facilitate the entry of short oligonu-
cleotides, plasmids, peptides, and proteins. Since the
discovery of the Antennapedia homeodomain (61), short
cationic peptides that are able to translocate the cell
membrane without disruption have caused much excite-
ment. These peptides were called cell-penetrating peptides
(CPPs) (62, 63). Since then, different CPPs have been
described, including Tat, Sweet Arrow peptide, transpor-
tan, and polyarginines (for review, see Reference (64)),
and their method of internalization has been extensively
studied, discussed, and has raised some controversy (65
69). To summarize, CPPs utilize more than one mechan-
ism of endocytosis to translocate through the plasma
membrane. Imaging of Tat peptide-conjugated quantum
dots in living cells has shown that the peptide-conjugated
nanomaterials are entering cells via macropinocytosis.
Tracking data demonstrated that the quantum dots-
loaded vesicles were actively transported by molecular
machines to an asymmetric perinuclear region (70).
Although this study was performed with quantum dots,
it is likely that the same mechanisms occur with gold
nanoparticles. Direct translocation of CPPs through the
membrane has also been reported, especially when they
are present in higher concentration and in the presence of
endocytotic inhibitors (67, 68). CPPs are attractive as a
transfection method, because only incubation is needed
and no physical disruption and manipulation of the
membrane is necessary.
Gold nanoparticles functionalized with CPPs have
been prepared and their efficiency for delivery has been
evaluated. There is a clear consensus that intracellular
uptake is increased by CPPs. However, the subcellular
localization and escape from endosomes is inconsistent.
Gold nanoparticles (3 nm) functionalized with Tat
peptide were shown by electron microscopy to be
localized in the nucleus and in the cytoplasm (71).
However, other studies using gold nanoparticles functio-
nalized with amphipatic proline-rich peptide (12 nm gold
nanoparticles-C-SAP) (72), Tat, or penetratin (10 nm
gold nanoparticles) (43) showed the nanoparticles
trapped in endosomes. Similar vesicular localization was
also observed with Tat-quantum dots (70). The large
discrepancy obtained between different studies can be
due to the cell lines used, the size of the cargoes (73), the
chemical composition of the capping layers (74), and
could also originate from artifacts coming from the
fixation required for electron microscopy (75). Careful
consideration of cell shape and viability must also
be taken into account. A number of studies claim
intracellular uptake and even nuclear localization, but
show pictures of dead/dying cells; such studies are not
significant as membrane permeability is a hallmark of
dying cells.
Nuclear localization has been observed using nuclear
localization sequences (NLS) in combination with CPPs
and PEG (43). However, only a few percent of nuclear
localization was achieved and most of the gold nanopar-
ticles remained trapped in endosomes. Mandal et al. also
observed endosomal localization using gold nanoparti-
cles capped with a monolayer composed of CPP and NLS
(76). Successful nuclear localization using microinjection
of gold nanoparticles ( 20 nm) capped with nucleoplas-
min (containing a NLS) was observed by Feldherr et al.
However, no nuclear import was observed with the NLS
sequence only (77). Tkachenko et al. have also observed
endosomal trapping and no nuclear localization using the
same NLS sequence from the SV40 large T antigen with
20 nm gold nanoparticles incubated on Hep2G cells (78,
79). The same team eventually managed to visualize, by
video-enhanced color differential interference contrast
(VEC-DIC) microscopy, nuclear delivery of gold nano-
particles using an adenoviral fiber protein containing
receptor-mediated endocytosis (RME) and NLS se-
quences. However, the unique cell shown as proof of
the successful delivery doesn’t look very healthy and is
likely to be engaged in a death program. This re-
emphasizes the requirement to assess the cell shape and
viability for these types of experiments to avoid artifacts.
Taken together, and excluding a number of studies
showing nuclear localization in dead cells, no conditions
where the majority of particles had a nuclear localization
has been achieved using NLS, indicating that endosomal
escape constitutes a prerequisite for successful intracel-
lular targeting.
Protein-mediated delivery: use of transferrin
Proteins have also been used as vectors to facilitate
delivery of gold nanoparticles. The interaction between
transferrin and its receptor has been used as a potential
pathway for cellular uptake of drugs and genes (80).
Transferrin plays an important role in iron transport for
hemoglobin synthesis. It has been successfully applied for
enhanced internalization of 20 nm gold nanoparticles
Raphae ¨lL e ´vy et al.
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monitored by atomic force microscopy (AFM) (81). The
uptake of 25 nm gold particles capped with transferrin
was also studied by laser scanning confocal microscopy
(82). The subcellular localization is not detailed in these
studies, yet the receptor-mediated endocytosis observed
by AFM (81) and the spotty fluorescent signal detected
by confocal microscopy (82) suggests endosomal locali-
zation. In a third study with particles of various sizes and
shapes, TEM and fluorescence imaging indicate endoso-
mal localization as well (57).
Transfection reagents
Polyethylenimine (PEI) is a polycationic molecule that
has been used as a DNA transfection agent due to the
charge-based interaction with negatively charged DNA.
It has been used to cap gold nanoparticles and enhance
siRNA and DNA delivery (83, 84). However, these
studies were not focused on the delivery of the gold
nanoparticles. Other cationic molecules, such as cationic
lipids, have been developed and are commercially avail-
able for the purpose of oligonucleotide transfection.
These compounds include Fugene-6, Effectene, Gene-
SHUTTLE, lipofectamine, etc. Again, gold nanoparticles
have been used in combination with these compounds to
enhance DNA transfection efficiency (85). We have used
Fugene-6 for gold nanoparticle delivery, and found that it
increased the aggregation of 10 nm CALNN-capped gold
nanoparticles (86). Although a high-level cellular uptake
was observed, all gold nanoparticles were localized inside
endosomes (Fig. 5). Similar results were obtained with
the protein delivery reagent BioPorter (86).
Liposomes
A liposome is a vesicle made out of a bilayer of
phospholipids that envelops a core aqueous compart-
ment. They can be composed of naturally derived
phospholipids or surfactant components. They have
been developed for drug delivery as they can carry either
hydrophilic (in the center) or hydrophobic (in the
membrane) molecules. Initially, the suggested mechanism
for delivery was their fusion with the plasma membrane
to deliver their contents into the cytosol, but it is now
accepted that the main delivery mechanism is endocytosis
(for review about cationic liposomes-based delivery, see
Reference (87)). One of the approaches to achieving gold
nanoparticles delivery is to incorporate the nanoparticles
inside or on the surface of the liposome. Liposome
intracellular uptake occurs via endocytosis leading to
the gold cargo delivery inside endosomes (43, 88). Small
gold nanoparticles (1.4 nm) have been successfully
delivered by liposomes into cancer cells (89). In this
case, the delivery efficiency was increased by 1,000 fold
for the small gold nanoparticles. Yet, again, the investiga-
tion of intracellular distribution clearly showed lysosomal
localization (final degrading organelles) within 40 min of
incubation (89).
Bacterial toxins
The use of toxins of microbial origin constitutes a
different approach for intracellular delivery. Fifteen years
ago, it was used for oligonucleotides delivery, especially
anti-sense oligonucleotides. They allow reversible per-
meabilization by transiently forming pores in the cell
membrane (9092). Streptolysin-O (SLO) increased by
more than 100 times the intracellular delivery of oligo-
deoxynucleotides in the KY01 myelogenous leukemia
cells compared to conditions without SLO (93, 94). More
recently, SLO has been successfully used for protein (95)
and peptide nucleic acid (PNA) delivery (96). We have
therefore tested this method on 10% CALNN-PEG 
90% CALNN functionalized gold nanoparticles (10
and 5 nm), and obtained improvement of cellular uptake
(Fig. 6), suggesting that this route has to be further
explored.
Listeriolysin O, another pore-forming toxin, is a thiol-
activated, cholesterol-dependent toxin protein. It differs
from other thiol-activated toxins, since its cytosolytic
activity is maximized at pH 5.5 (for review, see Reference
(97)). Its activity in low pH vesicles allows release of the
Fig. 5. TEM images of 10 nm CALNN-capped gold nanoparticles internalizedwith Fugene-6 (15 ml Fugene-6, 15 mM CALNN-
capped gold nanoparticles). TEM images clearly show endosomal localization as well as some large aggregates taken up by the
cells by macropinocytosis (right panel).
Gold nanoparticles delivery in mammalian live cells
Citation: Nano Reviews 2010, 1: 4889 - DOI: 10.3402/nano.v1i0.4889 7
(page number not for citation purpose)endosome content into the cytosol (98). This toxin loses
its activity in the neutral cytosol and has therefore
minimal toxicity (99). The use of these toxins is currently
not described for nanoparticles delivery, yet they might
offer attractive properties for cytoplasmic delivery.
Active delivery using physical methods
Several methods for active delivery involving disruption
of the cell membrane, physically or chemically, have been
tested with nanoparticles.
Sonoporation
Sonoporation uses ultrasound to generate transient non-
selective pores on the cell membrane and has been
exploited as an intracellular drug and gene delivery
strategy. The technique is based on ultrasound in con-
junction with microbubbles to drive the cargo into the cell
by causing violent bubble cavitation and jet streaming,
resulting in pore formation that may be followed by rapid
annealing if the membrane damage is not too severe. The
size of the pores has been estimated to be  110940 nm
in a Xenopus laevis oocytes model (102). A combination
of ultrasound and microbubbles has been used for
chemotherapeutic drug (103), siRNA (104), DNA (105),
and peptide (106) delivery. Ultrasound has been used for
delivery of 100 nm nanogold-dipalmitoyl phosphatidyl
ethanolamine (DPPE) that are not spontaneously inter-
nalized by endocytosis (101). It clearly increased intra-
cellular uptake, without causing significant cell death.
However, TEM images showed once again a vesicular
localization.
Genegun
Genegun is a physical means of molecule delivery. It uses
a high pressure helium gas burst to accelerate the cargo
and deliver it into the cells and was first described by
Klein et al. (107). It has primarily been used to transfect
cells with DNA or plasmids (in particular in plant cells).
Nanoparticles are frequently used as an adjuvant in these
studies, but their fate and localization is not reported
because the focus is on DNA transfection efficiency. It
has even been used in vivo for gene delivery into super-
ficial hepatocytes (108). It has recently been used to
transfer nanosensors into several adherent cell lines. The
cells displayed a good nuclear uptake of the nanosensor
according to the fluorescence levels and distribution
measured by confocal microscopy, but the viability
remained questionable according to the phase contrast
images (109).
Microinjection
Another mechanical delivery method is microinjection to
single cells. It allows control of the delivery dosage and
precise timing of delivery. It has been widely used in many
research areas, including the transfection of cells refrac-
tory to common transfection reagents such as primary
cells (for review, see Reference (110)). However, inap-
propriate manipulation (injection pressure, needle posi-
tioning) can lead to cytotoxicity or cellular stress.
Surprisingly, only a few papers show micro-injected gold
nanoparticles and their intracellular localization. It has
been reported with nucleoplasmin-capped gold nanopar-
ticles in BALB/c 3T3 cells (77). Targeted optical injection
of gold nanoparticles has recently been described by
Dholakia et al. (111). They have used a combination of
optical tweezing and opto-injection to deliver single 100
nm nanoparticles into the nucleus of single mammalian
cells. Although the approach is very neat and well
controlled, it seems to be technically extremely challen-
ging, requires sophisticated lasers, and is limited to large
nanoparticles. Laser irradiation has also been used with
1530 nm gold nanoparticles to increase membrane
permeabilization and nanoparticle delivery without caus-
ing cell death (112), but the intracellular distribution was
not evaluated.
Fig. 6. SLO enhances intracellular uptake of 10 nm gold nanoparticles. Overlay of a bright ﬁeld and a photothermal image of 5
nm gold nanoparticles (coated with 10% CCALNN-PEG  90% CALNN, 600 nM) delivered in HeLa cells with SLO (B)
compared to a control without SLO (A).
Raphae ¨lL e ´vy et al.
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The main limitation with all the techniques described
above is the ultimate vesicular localization and absence of
availability in the cytosol or in the nucleus in a healthy
living cell (for a summary, see Table 1). The same
limitations have already been discussed for quantum
dots (for review, see Reference (113)). In the field of
DNA and plasmid delivery, it has previously been shown
that lysosomotropic agents, such as chloroquine or
sucrose (114), can improve DNA delivery and subsequent
exogenous gene expression. Chloroquine is known to
induce vesicular disruption by elevating the intravesicular
pH of lysosomes and endosomes. We and others have
shown that chloroquine induces endosomal disruption
and increases the availability and stability of gold
nanoparticles inside the cells (85, 86), yet the effects are
not massive and the nanoparticles seem to stay in the
region of broken endosomes. Maiolo et al. have shown a
specific redistribution of fluorescently labeled cell-pene-
trating peptides from endosomes to cytoplasm using laser
illumination. The phototreatment is supposed to open
the endosomes without causing cell death for 24 h (115).
As yet, this attractive method has not been evaluated for
gold nanoparticles.
In the CPP field, the HA2 peptide has been used
in combination with penetrating peptides to increase
cytoplasmic delivery. HA2 is a 20 amino acid fusogenic
peptide from the influenza virus. It is a highly conserved
pH-sensitive sequence, which destabilizes plasma mem-
brane at low pH (116) and is therefore expected to escape
endosomal compartments (117). It has been used in
combination with polyarginine to increase transfection
efficiency (118). Gold nanoparticles capped with Tat-
HA2 have recently been successfully used for actin
filaments labeling with gold nanoparticles and live cell
detection of cytoskeleton dynamics (100).
Some strategies have been developed to avoid endoso-
mal uptake, by designing pH sensitive liposomes combined
with fusogenic peptides (119) or with the bacterial toxin
listerolysin O for DNA-nanoparticles delivery (119).
Interestingly, successful mitochondrial targeting of 10
nm gold colloids was achieved using functionalized
liposomes containing octa-arginine on the surface, which
enter cells via macro-pinocytosis and then fuse with the
mitochondrial membrane to deliver the cargo (MITO-
Porter) (120).
Measurements and detection in mammalian
cells
To understand the fate of gold nanoparticles in live cells
and their interactions with intracellular molecules or
compartments, it is necessary to combine complementary
Table 1. Comparison of gold nanoparticles subcellular localization using different methods of cellular delivery
Method Gold core size
(nm)
Capping Subcellular localization Toxicity Reference
CPP 16 94% PEG, 2% Tat, 2%
NLS, 2% penetratin
Cytoplasmic and nuclear Not reported 43
CPP  20 Nuclear localization
sequence and
receptor-mediated
endocytosis peptides
Nucleus  5% death 78
CPP 12 Sweet arrow peptide Endosomal Not reported 72
CPP 2.8 Tat peptide Cytosolic around the
mitochondria and in nucleus
Low cytotoxicity
below 10 mM
71; 68
CPP 20 Biotinylated Tat-HA2,
PEG-SH, anti-actin
antibodies
Cytoskeleton (cytoplasm) Not reported 100
PEI 4 PEI Mainly endosomal and some
nuclear localization
2030% death 83
SLO toxin 5 and 10 90% CALNN  10%
CALNN-PEG
Endosomal and cytosolic Toxicity controlled by
protocol optimization
Shaheen et al.,
unpublished
data
Liposomes 1.4 Phospholipid Lysosomes near the nuclear
membrane
Not reported 89
Transferrin 14100 Tranferrin Endosomal Nontoxic 57; 81
Ultrasound 100 DDPE Endosomal Non-toxic 101
Microinjection 1132 Nucleoplasmin Nuclear and cytoplasmic Not reported 77
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quantitative assessment of uptake, nanoparticle intracel-
lular localization, biochemical environment, and the fate
of the nanoparticle capping layer.
Direct measurements of the gold content: TEM, ICP-
AES, and ICP-MS
TEM is widely used for intracellular detection of metal
nanoparticles as it allows their direct visualization due to
their high electron density. In conventional TEM (as
opposed to high resolution TEM), nanoparticles above 5
nm can easily be detected inside cells because of the good
contrast provided by the high electron density of metal
nanoparticles. It is a powerful technique that permits
the visualization of single nanoparticles in cellular
compartments and organelles. However, it has rather
low throughput since it necessitates time-consuming
processing of the samples (cell fixation and resin embed-
ding). It also requires many images taken from a large
number of sliced cells to obtain significant results about
localization. Many studies reporting TEM experiments
show a single representative image, but important statis-
tical information, such as number of nanoparticles found,
number of images analyzed, number of different cells
imaged, are often missing (for review on quantification of
intracellular gold nanoparticles, see Reference 10).
TEM has been used to quantify the number of citrate-
coated gold nanoparticles in vesicles after uptake in
mammalian cells (49). Here, TEM results have been
further corroborated by inductively coupled plasma
atomic emission spectroscopy (ICP-AES). This technique
enables a count of the number of gold atoms, thereby
providing a more precise quantification of the number of
gold spheres, though following the same trendas the TEM
estimate. As for ICP-AES, inductively coupled plasma
mass spectrometry (ICP-MS) gives an elemental analysis
and, therefore, an estimate of the numberof nanoparticles
in the sample can be calculated. It has been successfully
used to study the uptake of Gd
III-enriched polyvalent
Cy3DNAgold nanoparticles conjugate (Cy3DNA
Gd
III@Au-NP) in NIH/3T3 and HeLa cells (121). These
methods require cell lysis of a large number of cells. They
provide, quantitatively, the average populationuptake at a
given time point, but do not reveal cell-to-cell variations,
dynamics, and intracellular localization.
Fluorescence
To detect gold nanoparticles by fluorescence, two options
can be used: a fluorescent label attached to the gold core
or a fluorescent gold core.
Fluorescent molecules
The use of fluorescent molecules attached to the gold
core is the most widely used. However, attention must
be drawn to the quenching effect of the gold core.
Depending on the distance between the fluorescent label
and the gold core (122), the size of the nanoparticle, and
the loading of the fluorescent dye on the nanoparticle
(123, 124), energy transfer may prevent photons from
being emitted (or enhance their emission). The molecule
should therefore be far enough from the gold core, and if
the fluorescent signal is to report on the localization of
the particle, independent proof that the conjugate is
intact should be provided. It has been shown that a
ligand can be removed on or after cell entry either by
ligand exchange (125) or proteolysis (86). The fluores-
cence can be measured by wild field microscopy (126) or,
for a better resolution, by laser scanning confocal
microscopy. The latter technique provides an image of a
thin section of the sample, thereby providing better
localization information. For example, the uptake of 3.5
nm lysine and FITC functionalized gold nanoparticles
was investigated in RAW264.7 macrophage cells by laser
confocal scanning microscopy (127).
Fluorescent gold clusters
Gold clusters have been shown to exhibit intrinsic
fluorescence that varies with the size of the cluster
(128). Chang’s group reported the synthesis of intrinsi-
cally fluorescent gold nanoclusters (AuNC@DHLA) of
less than 4 nm. These particles displayed less photo-
bleaching than organic fluorophores and successful
conjugations with PEG, PEG-biotin, and streptavidin
were achieved (129). They have been used to specifically
label endogenous biotin of HepG2 fixed cells and, in a
preliminary study, unconjugated AuNC@DHLA have
been imaged inside live HAEC cells as a ‘proof of
principle’ of their potential in live cell imaging (129).
Two other studies have reported internalization of
fluorescent gold clusters in living cells (130, 131). How-
ever, controls in the absence of nanoparticles are needed
(131), and in both cases fluorescence microscopy images
indicate endosomal localization, although Lin et al. claim
nuclear localization.
Scattering and absorption
Several recent papers have reviewed the optical proper-
ties of metal nanoparticles and their applications in
biosensing (24). Here, we focus on selected examples
of reports that use these techniques in the context of live
cells.
Dark field
Curry et al. studied the epidermal growth factor receptor
(EGFR) by dark-field microspectrometry and 60 nm gold
nanoparticles conjugated to anti-EGFR (132). Here, the
reflected dark-field imaging allowed visualization in live
cells of the receptor-mediated uptake of gold nanoparti-
cles and spectrometry allowed recording of the scattering
spectra of gold nanoparticles. Yet, the fact that individual
Raphae ¨lL e ´vy et al.
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scattering environment like a cell requires further evi-
dences. Anti-EGFR conjugated and unconjugated gold
nanoparticles were compared and different distributions
of peak wavelengths were found from the scattering data.
The unconjugated gold nanoparticles had a red-shifted
and broader distribution as compared to the conjugated
ones. The red-shift can be explained by the aggregation of
the nanoparticles, and indeed TEM images showed that
unconjugated gold nanoparticles were in endosomes in
close proximity to one another, when the anti-EGFR
conjugated particles were isolated. As mentioned in
Assisted endosomal escape section, Kumar et al. have
used 20 nm gold nanoparticles functionalized with an
anti-actin antibody for labeling actin in live cells (100).
The paper does not report single particle detection (and
the TEM shows a very high density of labels), but clearly
demonstrates the potential of dark field to improve the
understanding of nanoparticle interaction with cells.
Louit et al. have reported single particle imaging,
tracking, and spectroscopy using dark-field microscopy
on live cells (133). For this purpose, they used large 80 nm
nanoparticles, which allowed overcoming the scattering
background of the cells. To extract robust information
from single particle or single molecule studies, it is
normally necessary to look at hundreds of traces and to
carry out rigorous statistical analysis. Louit et al. did not
present such analysis, but their paper is a clear proof of
principle demonstration of the potential of this technique
to follow the interaction and uptake of single large gold
nanoparticles in live cells. They suggested that informa-
tion on the environment of the particle could be deduced
from an observed modulation in the scattering spectrum.
Plasmon coupling
Detection of biological events at the single molecule level
has been used for biosensing by exploiting the distance-
dependent scattering properties of the gold nanoparticles.
Using these properties, optical contrast between isolated
and closely spaced gold nanoparticles can be achieved
(differences in peak intensity and wavelength) (134136).
Inducing the close proximity of plasmonic particles in the
presence of a specific target can therefore provide a
sensor to probe molecular interactions (135). Nanopar-
ticle plasmon resonance coupling has allowed dynamic
imaging of growth factor states in living cells (137). A
recent application of the plasmon coupling in living cells
has been the detection of protease activation at single
molecule level. The signal provided by the plasmon rulers
based on optical imaging of crown gold nanoparticles
allowed continuous monitoring of caspase-3 activity in
live cells (138). Other ways of achieving sensor detection
in cells is to exploit the fluorescence quenching properties
of gold nanoparticles. This has successfully been devel-
oped to detect mRNA in living cells using nano-flares
(139). Plasmonic resonance energy transfer (PRET)
has been developed for ion metal sensing in living
HeLa cells (140).
Raman scattering
Surface Raman scattering (SERS) has also been used for
live cell probing. SERS can fulfill the requirements of
dynamic in vivo systems by using low laser powers and
short data acquisition times. Raman scattering occurs
during collision of photons with molecules. During this
process, photons gain or lose energy and this change in
energy results in scattered photons. A Raman spectrum is
generated by scattering from different molecular vibra-
tions and provides a vibrational fingerprint of a molecule
(for a review on SERS principle and applications, see
Reference 141). In SERS, Raman scattering signals can
be enhanced by several orders of magnitude for molecules
in the vicinity of metal nanostructures. For example, gold
nanoparticles can amplify the efficiencies of adsorbed
molecules by 10
14-t o1 0
15-fold, allowing spectroscopic
detection of single molecules. Applications are multiple
and range from chemical probing in intracellular com-
partments such as pH (141), to subcellular detection of 20
nm gold nanoparticles decorated with large T antigen
NLS (142) or in vivo tumor detection using PEGylated
SERS nanotags (143). Recently, time-resolved aquisition
of the SERS spectra has also allowed observation of
the transport of gold nanoparticles through a living cell
(144).
Differential interference contrast
Tkachenko et al. have studied the uptake of 20 nm gold
nanoparticles functionalized with different NLS se-
quences using VEC-DIC. The principle of the technique
seems appealing, as the gold nanoparticles are supposed
to appear as colored areas together with the shape and
topography of the cells provided by DIC on a single
image recorded at video rate (79). However, there is no
evidence of the possibility of individual nanoparticles
imaging and it is unclear how much uptake is required to
obtain a significant signal. More recently, a dual-wave-
length DIC microscopy has been developed to image 20
80 nm silver or/and gold nanoparticles, which is based on
the wavelength-dependent contrast of metal nanoparti-
cles (145). The technique has also been used to image the
entry of Tat-functionalized 40 nm gold nanoparticles in
live HeLa cells at video rates (145). The principle relies on
comparing two DIC images taken at the same time at two
different wavelengths; one at 540 nm corresponding to
the maximum contrast wavelength of gold nanoparticles
to detect the nanoparticles and the cells, and one at 720
nm as a control image to detect cells only. The DIC
contrast is not only depending on the size of the
nanoparticles, but also on the complex refractive indexes
of metal nanoparticles (145).
Gold nanoparticles delivery in mammalian live cells
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In 2002, Boyer et al. introduced photothermal imaging
of gold nanoparticles (17). It is an absorption-based
imaging technique that allows the direct imaging of
metal nanoparticles (146, 147), nanotubes (148), and
quantum dots (149). The technique relies on the
overlay of two laser beams, one that induces a small
localized temperature change ( 128C) if a nano-
absorber is present, the other that detects the eventual
change of temperature. It has further been used to
image membrane proteins using gold nanoparticles as
labels (150). It allowed detection of single small
nanoparticles (10 nm) for a long period of time
without blinking or photobleaching. The sensitivity of
the technique has since been improved to allow imaging
of 5 nm gold nanoparticles in living cells and the
technique was renamed laser-induced scattering around
a nano absorber (LISNA). Single nanoparticle photo-
thermal tracking (SNaPT) has been developed by the
same group and is able to achieve the tracking of metal
nanoparticles at video rate for long periods of time.
They have recorded the lateral movement of a mem-
brane protein AMPA receptor in live neurons via the
tracking of 5 nm AMPA receptor-conjugated gold
nanoparticles for more than 5 min (151). Photothermal
absorption correlation spectroscopy (PhACS), the
equivalent of fluorescence correlation spectroscopy
(FCS) with a detection based on the absorption of
metal nanoparticles, would also allow the measurement
of diffusion constants of metal nanoparticles and the
hydrodynamic radii of functionalized nanoparticles
(152), but it has not yet been applied to live cells.
Optoacoustic and photoacoustic tomography
(absorption)
Optoacoustic tomography (OAT) uses a pulsed laser that
produces a change of temperature localized in the vicinity
of any absorbing tissue or object. It creates an acoustic
wave that is detected and further reconstructed in a 2-D
or 3-D image. It has been reported in in vitro experiments
with 40 nm gold nanoparticles conjugated to an antibody
that targets human SK-BR-3 breast cancer cells (153).
Photoacoustic tomography (PAT) is also based on the
absorption of a pulsed laser by an absorbing object,
which creates a temperature change generating photo-
acoustic waves (154). Due to the dark-field configuration
of its illumination, the extracted signal produces better
quality images. PAT has been used with PEGylated gold
nanoparticles as a contrast agent for in vivo tumor
imaging in mice (155). One advantage of this technique
is the ability to image deep tissue and, therefore, has a
potential in ex vivo and in vivo cancer diagnostics and
therapeutics.
Integrity of the capping layer
To go beyond proofs of principle and develop robust
applications of bionanotechnology, a critical piece is
currently missing: very little is known about the fate of
the nanoparticle capping layer inside living cells. This
knowledge gap is due partly to the technical difficulty of
investigating nanoparticle surface properties after it has
been exposed to the complex environment of the cell. One
pioneering study in this field was the analysis of the
capping composition using laser desorption/ionization
mass spectrometry of cell lysates (156). This technique
provides a high level of chemical information, but is time
consuming and limited to fixed time points. As shown in
Fig. 7, we have used real-time fluorescence confocal
imaging on single living cells combined with photother-
mal imaging on fixed cells to simultaneously report on
the localization of the gold core and on the integrity of
the capping layer (in this case a peptide ligand shell) (86).
We demonstrated that peptide cleavage occurs during
nanoparticle uptake and we determined that Cathepsin L
was the protease responsible for the degradation. This
result is of general significance because one third of all
human proteins are potentially cleaved at least once by
Cathepsin L (86) and most applications of nanomaterials
require conjugation with peptides or proteins to encode
for specific recognition, targeting, or actuation. The
probability that such bionanoconjugates would degrade
during internalization is very high and yet has rarely been
discussed in the literature.
In summary, there is a range of methods available to
probe the amount of nanoparticles internalized, their
intracellular localization, their capping stability, and their
potential interactions. To progress towards the rational
design of nanoparticle-based sensors and actuators, it is
now necessary to systematically combine these tools to
obtain a comprehensive view of the bionanoconjugates
uptake, localization, and biochemical fate.
Conclusion
In this review, we have focused on intracellular delivery of
nanomaterials. We observe that in spite of the increasing
number of published papers, controlling the intracellular
delivery, fate, and intracellular localization of nanopar-
ticles remains a major challenge and even simple ques-
tions such as the effect of surface charge, chemical
functionalization, and size are still controversial. Clearly,
one of the major challenges is the endosomal trapping of
the nanomaterials taken up. For in vitro applications such
as nanoparticle-based imaging, disruptive methods such
as temporary permeation by physical or biochemical
means can be used. Even with such methods, particles are
generally found in endosomes demonstrating the power-
ful mechanisms that cells use to protect themselves from
foreign materials and organisms. Biology, however, also
Raphae ¨lL e ´vy et al.
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endosomes: some micro-organisms, such as viruses, are
able to disrupt the endosomal membrane to reach the
cytosol. Thus, there is hope that the challenge can be
overcome in a robust way using astutely designed
nanomaterials. This will require progress in understand-
ing in real time what happens to the particles and to their
coating immediately after incubation in cell medium,
during contact with the cellular membrane, and after
intracellular uptake. Combining existing and emerging
methods of investigations, with strong interdisciplinary
inputs from biology, chemistry and physics, we may
well achieve ‘virus-like’ nanoparticles in the near future.
Other issues will include control of the intracellular
mobility, targeting to specific proteins and DNA targets,
but it will only be possible to start addressing these
challenges seriously once a robust path to the cytosol is
found.
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Fig. 7. Cathepsin-dependent cleavage of the peptide monolayer. Adapted with permission from See et al. (86). Copyright 2009
American Chemical Society. HeLa cells were incubated for 4 h with 6 nM of ﬂuorescently labeled 10 nm peptide-capped gold
nanoparticles. (AD) Confocal images of ﬂuorescence release inside cells after 4 h incubation, (A) nanoparticles only, (B)
nanoparticles in the presence of 100 mM chloroquine, (C) nanoparticles in the presence of 20 mM Z-FF-fmk (irreversible
cathepsin inhibitor), (D) nanoparticles in the presence of both 100 mM chloroquine and 20 mM Z-FF-fmk. (E) Quantiﬁcation of
ﬁve different ﬁelds for each condition described in AD. (FI) Photothermal images of nanoparticle uptake, (F) nanoparticles
only, (G) nanoparticles in the presence of 100 mM chloroquine, (H) nanoparticles in the presence of 20 mM Z-FF-fmk, (I) gold
nanoparticles in the presence of both 100 mM chloroquine and 20 mM ZFF-fmk. (K) Quantiﬁcation of photothermal intensity
for each condition described in AD. Average intensity of at least 40 cells is shown for each condition. Uptake is not affected by
chloroquine or Z-FF-fmk, but degradation of the monolayer is reduced by chloroquine and suppressed by Z-FF-fmk.
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